← All trials
NCT02385019
Phase 1/Phase 2Interventional
Trials that are a combination of phases 1 and 2.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Mar 1, 2015
- Primary completion
- Mar 1, 2019
- Completion date
- Dec 1, 2019
- First posted
- —
- Last posted
- —
- Enrollment
- 22
- Arms / groups
- 4 / —
- Source
- AACT · pre-existing
Sponsors
- Instituto de Medicina MolecularLead sponsor
- Instituto de Medicina MolecularReponsible party - principal investigator
- instituto Portugues de Oncologia PortoCollaborator
- University of LisbonCollaborator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.